Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitrectomy and drug combined therapy for idiopathic epiretinal membrane
ChiCTR-IPR-16008503Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Third Military Medical University,PLA
- Start
- May 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of ranibizumab and triamcinolone acetonide in chorioretinal scar (3 arms), sponsored by The First Affiliated Hospital of Third Military Medical University,PLA. Started May 2016; status: recruiting.
02
Drugs
ranibizumabtriamcinolone acetonide
03
Conditions
chorioretinal scar
Beyond the preview
Go deeper on ChiCTR-IPR-16008503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008503.